Notification in terms of Section 3.83(b) of the JSE Listings Requirements and Section 122(3)(b) of the Companies Act
Notification in terms of Section 3.83(b) of the JSE Listings Requirements and Section 122(3)(b) of the Companies Act Ascendis Health Limited (Registration number 2008/005856/06) (Incorporated in the Republic of South Africa) Share code: ASC ISIN: ZAE000185005 (“Ascendis Health” or “the Company”) NOTIFICATION IN TERMS OF SECTION 3.83(b) OF THE JSE LISTINGS REQUIREMENTS AND SECTION 122(3)(b) OF THE COMPANIES ACT In accordance with paragraph 3.83(b) of the Listings Requirements of the JSE Limited and section 122(3)(b) of the Companies Act 71 of 2008 (“the Act”), shareholders are advised of the following: Kefolile Health Investments Proprietary Limited has formally notified the Company that, in terms of section 122(1)(a) of the Act, it has acquired a beneficial interest in the ordinary shares of Ascendis Health, such that its total interest in Ascendis Health is 11.71%. As required in terms of section 122(3)(a) of the Act, the Company has filed the required notice with the Takeover Regulation Panel. 19 July 2021 Bryanston Sponsor Questco Corporate Advisory Proprietary Limited Date: 19-07-2021 03:37:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.